Brief Report: Potential Gains in PrEP Coverage and Effect on Racial Disparities After Introduction of On-Demand and Long-Acting Injectable PrEP: Preferences of Men Who Have Sex With Men in the United States, 2021–2022
Most GBMSM not willing to use daily oral PrEP are also not willing to use other modalities of PrEP; most GBMSM who are currently using daily oral PrEP prefer to continue using that dosing strategy. Our results suggest that differential preferences in modalities of PrEP will not exacerbate existing disparities in PrEP distribution or HIV incidence.
Authors
- Travis Sanchez (ORCID: https://orcid.org/0000-0003-1133-4762)
- Ignacio Lucas (ORCID: https://orcid.org/0000-0001-9426-5082)
- Aaron J. Siegler (ORCID: https://orcid.org/0000-0001-5553-7540)
- Jennifer L. Glick (ORCID: https://orcid.org/0000-0003-3323-1983)
- Patrick S. Sullivan (ORCID: https://orcid.org/0000-0002-7728-0587)
- Leigh Ragone
- Supriya Sarkar (ORCID: https://orcid.org/0000-0001-8495-5039)
- Jeb Jones (ORCID: https://orcid.org/0000-0001-9165-1658)
- Vani Vannappagari (ORCID: https://orcid.org/0000-0002-0157-9689)
- M. Keith Rawlings (ORCID: https://orcid.org/0009-0007-5545-421X)
Institutions
- Emory University (US)
- Louisiana State University Health Sciences Center New Orleans (US)
Publication Details
- Journal
- JAIDS Journal of Acquired Immune Deficiency Syndromes
- Published
- 2025-01-09
- DOI
- https://doi.org/10.1097/qai.0000000000003602
- Primary Topic
- HIV/AIDS Research and Interventions
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- ViiV Healthcare
- National Institute of Allergy and Infectious Diseases